Dementia vs. Delirium

Comparison of Dementia and Delirium

  • Dementia Characteristics

    • Classification: Chronic and permanent condition.
    • Onset: Gradual onset.
    • Progression: Declines over time.
    • Common Examples:
      • Vascular dementia.
      • Alzheimer disease.
      • Parkinson disease.
    • Clinical Goal: Focus on managing symptoms.
  • Delirium Characteristics

    • Classification: Acute and reversible condition.
    • Onset: Abrupt onset.
    • Progression: Waxes and wanes (fluctuating levels of consciousness).
    • Triggers: Tied to a specific physical or environmental trigger.
    • Common Examples:
      • Hospitalization.
      • Infection.
  • Shared Symptoms (S/S Dementia & Delirium)

    • Cognitive impairment.
    • Confusion.
    • Memory issues.
    • Agitation.
    • Disorientation.

Risk Reduction and Prevention Strategies

  • Dementia Risk Reduction

    • Nutrition and Lifestyle: Good nutrition and regular exercise.
    • Mental Health: Stress reduction activities.
    • Cognitive Health: Stay engaged, remain active, and seek new challenges.
    • Brain Protection:
      • Trauma prevention (Protect your brain!).
      • Vascular health management.
      • Alcohol use monitoring/limitation.
  • Delirium Risk Reduction

    • Environment: Keep the patient oriented and maintain sleep-wake cycles (e.g., keep blinds open during the day!).
    • Physiological Management: Limit periods of hypoxia and ensure good nutrition.
    • Pharmacological Precautions: Avoid opioids and sedation whenever possible.
    • Awareness: Stay engaged and informed.

The Montreal Cognitive Assessment (MOCA)

  • Overview

    • Version: 7.17.1 Original Version (by Z.NasreddineMDZ. Nasreddine MD).
    • Total Possible Score: 3030 points.
    • Education Adjustment: Add 11 point if the subject has 12\le 12 years of education.
  • Assessment Components

    • Visuospatial/Executive (55 points total):
      • Alternating Trail Making (1A2B1 \rightarrow A \rightarrow 2 \rightarrow B, etc.).
      • Copying a cube (11 point).
      • Clock Drawing: Must include Contour, Numbers, and Hands set to "Ten past eleven" (33 points).
    • Naming (33 points total): Identification of animal illustrations (e.g., Lion, Rhinoceros, Camel).
    • Memory:
      • Read a list of words: Face, Velvet, Church, Daisy, Red.
      • Two trials are performed even if the first is successful.
      • No points are awarded for these initial trials; points are only given for uncued delayed recall.
    • Attention (66 points total):
      • Forward digit span: Repeat 2,1,8,5,42, 1, 8, 5, 4.
      • Backward digit span: Repeat 7,4,27, 4, 2 (11 point).
      • Vigilance: Tap hand at each letter AA during a read list (F,B,A,C,M,N,A,A,J,K,L,B,A,F,A,K,D,E,A,A,A,J,A,M,O,F,A,A,BF, B, A, C, M, N, A, A, J, K, L, B, A, F, A, K, D, E, A, A, A, J, A, M, O, F, A, A, B). No points if errors 2\ge 2.
      • Serial 77 Subtraction: Start at 100100. Sequence: 100,93,86,79,72,65100, 93, 86, 79, 72, 65. (Scoring: 454-5 correct = 33 pts, 232-3 correct = 22 pts, 11 correct = 11 pt).
    • Language (33 points total):
      • Sentence repetition: "I only know that John is the one to help today" and "The cat always hid under the couch when dogs were in the room."
      • Verbal Fluency: Name the maximum number of words beginning with the letter FF in 11 minute (Target is 11\ge 11 words).
    • Abstraction (22 points total): Determine similarities between word pairs (e.g., banana-orange = fruit; train-bicycle; watch-ruler).
    • Delayed Recall (55 points total): Recalling the word list (Face, Velvet, Church, Daisy, Red) after 55 minutes. Points for uncued recall only. (Optional cues: Category or Multiple choice).
    • Orientation (66 points total): Date, Month, Year, Day, Place, City.
  • MOCA Scoring Thresholds

    • Normal Cognitive Function: 26/30\ge 26/30
    • Mild Cognitive Impairment: 182518-25
    • Moderate Cognitive Impairment: 101710-17
    • Severe Cognitive Impairment: <10< 10

Progression Stages of Dementia

  • Mild Dementia

    • Short-term memory loss.
    • Aware of issues; may attempt to hide memory loss.
    • Slow decline in cognitive ability.
    • Difficulty learning new things.
    • Planning difficulties.
    • Mood or personality changes; social withdrawal.
    • Starts to require cues or assistance with Activities of Daily Living (ADLs).
  • Moderate Dementia

    • Needs repeated instruction, even for simple tasks.
    • Severe memory loss (may not recognize family members).
    • Wandering behavior.
    • Needs consistent cues and assistance with ADLs.
    • Paranoia and outbursts.
    • Often requires round-the-clock supervision.
  • Severe Dementia

    • Unable to speak or ambulate.
    • Severe difficulty swallowing.
    • Significant weight loss.
    • Risks as mobility and nutrition decline:
      • Pressure injuries.
      • Respiratory failure.
      • Contractures.
      • Pneumonia.

Management Approaches

  • Delirium Specific Management

    • Reorient the patient.
    • Provide reassurance.
    • Explain all aspects of care.
  • Dementia Specific Management

    • Do NOT correct the patient.
    • Validate feelings.
    • Use redirection.
  • Integrated Management (Used for Both)

    • Maintain a calm approach.
    • Involve the patient in care as much as possible.
    • Individualized Care: Tailor the environment to established habits. Example: If a patient always exits the bed on the left side, the walker should be placed on the left side to ensure safety and comfort.

Pharmacological Interventions

  • Donepezil

    • Class: Cholinergic.
    • Onset: 343-4 hours.
    • Half-life: Exceptionally long (100+100+ hours).
    • Dosing Protocol: Requires slow increase in dosing.
    • Side Effects: Nausea, vomiting, diarrhea (N/V/DN/V/D), insomnia, muscle cramps, fatigue, anorexia, and bradycardia.
  • Rivastigmine

    • Class: Cholinergic.
    • Administration: Available PO (oral) or TD (transdermal) patches.
    • Clinical Note: Patches are specifically helpful for patients with severe dementia who may lose the ability to swallow or regularly refuse oral pills.
    • Dosing Protocol: Slow dose increases.
    • Side Effects: Nausea, vomiting (N/VN/V), muscle cramps, and sleep disturbance.
  • Memantine

    • Class: NMDA-receptor antagonist.
    • Dosing Protocol: Titration can be ramped up weekly rather than every 22 weeks.
    • Side Effects: Headache, dizziness, confusion, diarrhea or constipation, fatigue, hypertension, aggressive behavior, abdominal pain, and urinary incontinence.